Diagnosis and management of autoimmune hepatitis

L Muratori, AW Lohse, M Lenzi - bmj, 2023 - bmj.com
Autoimmune hepatitis is an inflammatory disease of the liver of unknown cause that may
progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment …

Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: a systematic review

T Zhou, H Guan, L Wang, Y Zhang, M Rui… - Frontiers in Public …, 2021 - frontiersin.org
Background: The EQ-5D-5L is a generic preference-based questionnaire developed by the
EuroQol Group to measure health-related quality of life (HRQoL) in 2005. Since its …

[PDF][PDF] Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study …

CL Mack, D Adams, DN Assis, N Kerkar… - …, 2020 - Wiley Online Library
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALF, acute liver failure; ALT, alanine aminotransferase; AMA …

Recent updates on the management of autoimmune hepatitis

A Komori - Clinical and molecular hepatology, 2020 - pmc.ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is an immunoinflammatory chronic liver disease with dynamic
and rather heterogeneous disease manifestations. A trend of increasing prevalence of AIH …

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

G Wang, A Tanaka, H Zhao, J Jia, X Ma… - Hepatology …, 2021 - Springer
Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· Xiong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …

[HTML][HTML] Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review

LL Grønkjær, MM Lauridsen - JHEP Reports, 2021 - Elsevier
Background & Aims In an attempt to uncover unmet patient needs, this review aims to
synthesise quantitative and qualitative studies on patients' quality of life and their experience …

Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European Reference Network on Hepatological Diseases and the …

AW Lohse, M Sebode, MH Jørgensen, H Ytting… - Journal of …, 2020 - Elsevier
Most patients with autoimmune hepatitis respond well to standard immunosuppressive
therapy with steroids and azathioprine, and while untreated disease is usually fatal, patients …

[HTML][HTML] Autoimmune hepatitis: 2019 update

A Tanaka - Gut and Liver, 2020 - ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease, characterized by the
elevation of aminotransferases, presence of anti-nuclear antibody or anti-smooth muscle …

Regulatory T cells in autoimmune hepatitis: unveiling their roles in mouse models and patients

H Wang, X Feng, W Yan, D Tian - Frontiers in Immunology, 2020 - frontiersin.org
Autoimmune hepatitis (AIH) is a severe and chronic liver disease, and its incidence has
increased worldwide in recent years. Research into the pathogenesis of AIH remains limited …

The role of B cells and B cell therapies in immune-mediated liver diseases

T Cargill, EL Culver - Frontiers in Immunology, 2021 - frontiersin.org
B cells form a branch of the adaptive immune system, essential for the body's immune
defense against pathogens. B cell dysfunction has been implicated in the pathogenesis of …